https://stockhub.co/index.php?action=history&feed=atom&title=Samjin_Pharmaceuticals_Co.%2C_Ltd. 2026-04-09T22:09:08Z Revision history for this page on the wiki MediaWiki 1.43.5 https://stockhub.co/index.php?title=Samjin_Pharmaceuticals_Co.,_Ltd.&diff=67752&oldid=prev 2022-09-22T07:41:04Z

<p>Created page with &quot;== Summary&lt;ref&gt;Source: Yahoo Finance.&lt;/ref&gt; == Samjin Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in Korea. The company&#039;s products include SA001, a clinical Phase II product for the treatment of dry eye and sjogren syndrome; SJP1803/1804, a preclinical stage product for the treatment of macular degeneration; SJP601 and SJP1602 preclinical stage products for the treatment of cancer; SPJ1604 and SPJ003 clinical phase produc...&quot;</p> <p><b>New page</b></p><div>== Summary&lt;ref&gt;Source: Yahoo Finance.&lt;/ref&gt; ==<br /> <br /> Samjin Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in Korea. The company&#039;s products include SA001, a clinical Phase II product for the treatment of dry eye and sjogren syndrome; SJP1803/1804, a preclinical stage product for the treatment of macular degeneration; SJP601 and SJP1602 preclinical stage products for the treatment of cancer; SPJ1604 and SPJ003 clinical phase products for the treatment of cancer and diabetes; and SJP1901, SJP1902, SJP1801, and SJP006 biological testing stage products for the treatment of cancer, fibrosis, cancer immunotherapy, alzheimer&#039;s disease, Parkinson&#039;s disease, and anti-viral disease. The company was founded in 1968 and is headquartered in Seoul, South Korea.<br /> <br /> == References and notes == <br /> [[Category:Thesis]]<br /> __INDEX__</div>

95.149.241.133